DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

about

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

Item

http://www.wikidata.org/entity/Q50861643

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年学术文章

@wuu

2016年学术文章

@zh-cn

2016年学术文章

@zh-hans

2016年学术文章

@zh-my

2016年学术文章

@zh-sg

2016年學術文章

@yue

2016年學術文章

@zh

2016年學術文章

@zh-hant

name

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@en

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@nl

type

Item

label

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@en

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@nl

prefLabel

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@en

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@nl

P1476

DNA Vaccines: A Strategy for Developing Novel Multivalent TB Vaccines.

@en

P2093

Daniel O Villarreal

http://www.w3.org/2001/XMLSchema#string

David B Weiner

http://www.w3.org/2001/XMLSchema#string

Jaemi S Chu

http://www.w3.org/2001/XMLSchema#string

P2860

Synthetic DNA vaccine strategies against persistent viral infections

Safety and efficacy of MVA85A, a new tuberculosis vaccine, in infants previously vaccinated with BCG: a randomised, placebo-controlled phase 2b trial

Alarmin IL-33 acts as an immunoadjuvant to enhance antigen-specific tumor immunity

An optimized, synthetic DNA vaccine encoding the toxin A and toxin B receptor binding domains of Clostridium difficile induces protective antibody responses in vivo

Immunotherapy against HPV16/18 generates potent TH1 and cytotoxic cellular immune responses.

Induction of antitumor immunity in vivo following delivery of a novel HPV-16 DNA vaccine encoding an E6/E7 fusion antigen.

Development of 2A peptide-based strategies in the design of multicistronic vectors.

Multivalent TB vaccines targeting the esx gene family generate potent and broad cell-mediated immune responses superior to BCG.

Safety and comparative immunogenicity of an HIV-1 DNA vaccine in combination with plasmid interleukin 12 and impact of intramuscular electroporation for delivery

A picornaviral 2A-like sequence-based tricistronic vector allowing for high-level therapeutic gene expression coupled to a dual-reporter system.

P304

355-361

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/978-1-4939-3387-7_18

http://www.w3.org/2001/XMLSchema#string

P407

English

P478

1403

http://www.w3.org/2001/XMLSchema#string

P577

2016-01-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27076140

http://www.w3.org/2001/XMLSchema#string